Shanghai Allist Pharmaceuticals Co., Ltd.

Equities

688578

CNE100005XJ7

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. 06:00:00 2024-05-28 pm EDT 5-day change 1st Jan Change
57.51 CNY -0.26% Intraday chart for Shanghai Allist Pharmaceuticals Co., Ltd. -2.89% +38.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chart Shanghai Allist Pharmaceuticals Co., Ltd.
More charts
Shanghai Allist Pharmaceuticals Co Ltd is a China-based company focusing on the field of tumor treatment. The Company has built a research and development pipeline in the field of small molecule targeted drugs for non-small cell lung cancer. The Company has established a complete new drug research and development system, covering all aspects of lead drug discovery and optimization, candidate drug evaluation and establishment, drug preclinical and clinical research, drug registration and application, industrialization and commercialization. The Company has a number of research pipeline projects under development, such as vometinib. Its drugs are used in the fields of blood pressure reduction, anti-tumor, anti-diabetic and gastric acid related diseases.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
57.51
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688578 Stock
  4. News Shanghai Allist Pharmaceuticals Co., Ltd.
  5. Shanghai Allist Pharmaceuticals Gets Nod to Advance Trial of Lung Cancer Treatment